Candel Therapeutics, Inc.CADLNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank33
Studio
Year-over-Year Change

Free cash flow yield

Latest
-13.00%
↑ 52% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-27.24%
Historical baseline
PeriodValueYoY Change
2025-13.00%-32.2%
2024-9.83%+87.9%
2023-81.58%-28.7%
2022-63.41%-491.5%
2021-10.72%-33.2%
2020-8.05%-97.7%
2019-4.07%-